to identify novel compounds inhibiting henipavirus replication for pandemic antiviral preparedness | Pandemic PACT Tracker

Key facts

Disease
Unspecified
Start & end year
2022
Known Financial Commitments (USD)
$1,996,634
Funder
Gates Foundation
Research Location
United States of America
Lead Research Institution
Icahn School of Medicine at Mount Sinai
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

N/A

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses.